sanofi pasteur, Acambis Campus
38 Sidney Street
Cambridge
Massachusetts
02139
United States
Tel: 617-761-4200
Fax: 617-464-1742
Website: http://www.acambis.com/
Email: acambis@acambis.com
About sanofi pasteur, Acambis Campus
Acambis is a leading developer of vaccines to prevent and treat infectious diseases. Recognized internationally as the leading producer of smallpox vaccines, Acambis is developing an investigational smallpox vaccine, ACAM2000, and is manufacturing emergency-use stockpiles of this investigational vaccine for the US Government and other governments around the world. In January 2006, Acambis submitted the first portion of a Biologics License Application with the FDA to seek licensure for the vaccine and expects a decision by the FDA by the end of the year. Acambis is also developing an attenuated smallpox vaccine, MVA3000, under contracts with the US National Institutes of Health.
Acambis’ Miami-based subsidiary Berna Products Corporation markets Vivotif®, the world's only licensed oral typhoid vaccine, in North America. The company’s investigational vaccine against Japanese encephalitis, ChimeriVax-JE, is undergoing Phase 3 clinical testing. Acambis also has the most advanced investigational vaccine against the West Nile virus, which has spread to 48 states in the last six years, and a vaccine against Clostridium difficile bacteria, a leading cause of hospital-acquired infections.
Acambis is based in Cambridge, UK and Cambridge, Massachusetts, with operations in Canton, Massachusetts; Rockville, Maryland; and Miami, Florida. We invite you to learn more about Acambis and our employment opportunities at www.acambis.com.
Last Updated: 02-15-2006
9 articles about sanofi pasteur, Acambis Campus
-
Vivalis Grants Research License to Acambis to Evaluate E B66(R) Cell Line for Viral Vaccines Production
7/8/2008
-
Crucell N.V. Announces PER.C6(R) Licensing Agreement with Acambis
11/20/2007
-
Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine
11/13/2007
-
Acambis Says Japanese Encephalitis Trial Positive
10/30/2006
-
Acambis PLC Release: Research Update
9/12/2006
-
Acambis PLC - Acambis Wins MVA Case
9/7/2006
-
Peter Fellner To Become New Chairman Of Acambis
7/12/2006
-
BioSpace, Inc. And Massachusetts Biotechnology Council, Inc. Unveil 2006 Genetown™ Campaign
12/15/2005
-
Cangene Corporation Wins UK Government Contract With Acambis PLC For $14.4 Million
9/19/2005